ARTICLE | Company News
Medicines Co. gets approvable letter
May 17, 2000 7:00 AM UTC
The Medicines Co. ( Cambridge, Mass.) received an approvable letter from the FDA for its Angiomax bivalirudin anticoagulant thrombin inhibitor to treat patients with unstable angina undergoing angioplasty. Angiomax is approved for marketing in New Zealand. ...